| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NKGen Biotech, Inc. | Chief Financial Officer | Stock Option (right to buy) | 500,000 | 06 Dec 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NKGN | NKGen Biotech, Inc. | 06 Dec 2024 | 1 | $0 | 4 | Chief Financial Officer | 10 Dec 2024, 21:55 |
| NKGN | NKGen Biotech, Inc. | 01 Dec 2023 | 2 | $2,172 | 4 | Interim CFO | 05 Dec 2023, 15:50 |
| NKGN | NKGen Biotech, Inc. | 20 Nov 2023 | 2 | $67.00 | 4 | Interim CFO | 22 Nov 2023, 17:55 |
| GFOR | Graf Acquisition Corp. IV | 28 May 2021 | 2 | $49,500 | 4 | Chief Executive Officer | 03 Jun 2021, 06:03 |
| GFOR | Graf Acquisition Corp. IV | 25 May 2021 | 3 | $4,959 | 4 | Chief Executive Officer | 27 May 2021, 16:57 |
| GFOR | Graf Acquisition Corp. IV | 21 May 2021 | 3 | $12,923 | 4 | Chief Executive Officer | 25 May 2021, 19:45 |